Vinorelbine in Mesothelioma (VIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02139904
Recruitment Status : Recruiting
First Posted : May 15, 2014
Last Update Posted : April 11, 2017
Pierre Fabre Laboratories
Information provided by (Responsible Party):
Wales Cancer Trials Unit

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 1, 2018
  Estimated Study Completion Date : December 1, 2018